Fundraising FoxAhren Innovation Capital — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Bicycle Therapeutics develops precision-guided therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, designed to penetrate deep into tissues and target intractable solid tumor cancers.
BiotechHealthtechCambridge, GB
Gregory Winter(Director)inKEVIN LEE(Executive Officer, Director)inNIGEL CROCKETT(Executive Officer)inNICHOLAS KEEN(Executive Officer)SANTIAGO ARROYO(Executive Officer)inMICHAEL HANNAY(Executive Officer)
Co-investorsAstellas Venture Management LLCCambridge Innovation CapitalDementia Discovery FundLongwood FundRidgeback CapitalSR One Capital Management+4 more
Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.
BiotechDeep TechNew Materials
Jason Chin(Professor)
Co-investors+ND CapitalAmadeus Capital PartnersFine Structures VenturesGENERAL INCEPTIONLongeVCOMX Ventures+2 more
Heirloom operates Direct Air Capture (DAC) facilities that use limestone and carbon mineralization technology to permanently remove CO2 from the atmosphere at scale.
CleantechClimate TechDeep TechCalifornia, US
Shashank Samala(Founder & CEO)in
Co-investorsAENUAutodesk FoundationBreakthrough Energy VenturesBreyer CapitalCarbon Removal PartnersCollaborative Fund+10 more
.jpeg){kind=logo}
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.
AI & Machine LearningBiotechLongevityMedical Devices
Co-investorsAlumni VenturesBeiersdorf Innovation FundCDP Venture CapitalEvolution VenturesIKJ CapitalKhosla Ventures+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.